Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1970 2
1973 2
1974 2
1977 3
1978 2
1979 2
1980 1
1981 1
1983 1
1985 3
1986 2
1987 4
1988 5
1989 1
1990 4
1991 1
1993 3
1994 4
1995 1
1996 4
1997 4
1998 2
1999 1
2000 1
2001 1
2002 1
2004 5
2006 3
2007 4
2009 3
2010 7
2011 16
2012 2
2013 3
2014 9
2015 9
2016 5
2017 7
2018 5
2019 3
2020 3
2021 4
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Clinical Trial.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, André M, Fournier M, Gaulard P, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA) investigators. Peyrade F, et al. Lancet Oncol. 2011 May;12(5):460-8. doi: 10.1016/S1470-2045(11)70069-9. Epub 2011 Apr 7. Lancet Oncol. 2011. PMID: 21482186 Clinical Trial.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study.
Joris S, Denys H, Collignon J, Rasschaert M, T'Kint de Roodenbeke D, Duhoux FP, Canon JL, Tejpar S, Mebis J, Decoster L, Aftimos P, De Grève J. Joris S, et al. Among authors: collignon j. ESMO Open. 2023 Dec;8(6):102041. doi: 10.1016/j.esmoop.2023.102041. Epub 2023 Oct 16. ESMO Open. 2023. PMID: 37852034 Free PMC article. Clinical Trial.
[Management of febrile neutropenia in cancer patients].
Freres P, Gonne E, Collignon J, Giot JB, Gennigens C, Jerusalem G. Freres P, et al. Among authors: collignon j. Rev Med Liege. 2015 Apr;70(4):195-200. Rev Med Liege. 2015. PMID: 26054171 Free article. Review. French.
[BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].
Jerusalem G, Collignon J, Josse C, Schroeder H, Rorive A, Frères P, Lambert F, Koopmansch B, Poncin A, Bours V. Jerusalem G, et al. Among authors: collignon j. Rev Med Liege. 2015 May-Jun;70(5-6):269-76. Rev Med Liege. 2015. PMID: 26285451 Free article. Review. French.
[Comprehensive therapeutic strategy for localized esophageal cancer].
Van Daele D, Honoré P, Collignon J, Polus M, Loly C, Mutijima E, De Roover A, Coucke PA, Louis E, Martinive P. Van Daele D, et al. Among authors: collignon j. Rev Med Liege. 2017 Feb;72(2):58-63. Rev Med Liege. 2017. PMID: 28387081 Free article. Review. French.
152 results